Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SAMRAT PHARMA GLENMARK PHARMA SAMRAT PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 4,683.0 -31.4 - View Chart
P/BV x 1.6 2.9 57.1% View Chart
Dividend Yield % 0.3 0.3 114.9%  

Financials

 SAMRAT PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    SAMRAT PHARMA
Mar-23
GLENMARK PHARMA
Mar-23
SAMRAT PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,250487 256.6%   
Low Rs332349 95.2%   
Sales per share (Unadj.) Rs1,005.3460.4 218.4%  
Earnings per share (Unadj.) Rs53.813.4 402.4%  
Cash flow per share (Unadj.) Rs55.935.0 159.5%  
Dividends per share (Unadj.) Rs1.002.50 40.0%  
Avg Dividend yield %0.10.6 21.1%  
Book value per share (Unadj.) Rs204.3335.1 61.0%  
Shares outstanding (eoy) m3.09282.17 1.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.80.9 86.6%   
Avg P/E ratio x14.731.3 47.0%  
P/CF ratio (eoy) x14.111.9 118.6%  
Price / Book Value ratio x3.91.2 310.3%  
Dividend payout %1.918.7 9.9%   
Avg Mkt Cap Rs m2,444117,953 2.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1127,810 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,106129,901 2.4%  
Other income Rs m53,168 0.2%   
Total revenues Rs m3,111133,069 2.3%   
Gross profit Rs m23915,125 1.6%  
Depreciation Rs m66,113 0.1%   
Interest Rs m123,496 0.4%   
Profit before tax Rs m2258,685 2.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m594,911 1.2%   
Profit after tax Rs m1663,774 4.4%  
Gross profit margin %7.711.6 66.2%  
Effective tax rate %26.256.5 46.3%   
Net profit margin %5.42.9 184.3%  
BALANCE SHEET DATA
Current assets Rs m98698,737 1.0%   
Current liabilities Rs m52850,455 1.0%   
Net working cap to sales %14.837.2 39.7%  
Current ratio x1.92.0 95.5%  
Inventory Days Days87 120.1%  
Debtors Days Days602115 522.8%  
Net fixed assets Rs m17576,920 0.2%   
Share capital Rs m31282 11.0%   
"Free" reserves Rs m60194,281 0.6%   
Net worth Rs m63194,563 0.7%   
Long term debt Rs m038,521 0.0%   
Total assets Rs m1,162175,658 0.7%  
Interest coverage x19.33.5 553.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x2.70.7 361.7%   
Return on assets %15.44.1 371.6%  
Return on equity %26.34.0 659.9%  
Return on capital %37.69.2 411.2%  
Exports to sales %4.10-   
Imports to sales %83.30-   
Exports (fob) Rs m127NA-   
Imports (cif) Rs m2,587NA-   
Fx inflow Rs m12746,464 0.3%   
Fx outflow Rs m2,58712,712 20.3%   
Net fx Rs m-2,46033,751 -7.3%   
CASH FLOW
From Operations Rs m-946,254 -1.5%  
From Investments Rs m-30-5,285 0.6%  
From Financial Activity Rs m96-775 -12.4%  
Net Cashflow Rs m-28325 -8.7%  

Share Holding

Indian Promoters % 48.6 46.7 104.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.2 34.7 9.3%  
FIIs % 0.0 23.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 51.4 53.4 96.3%  
Shareholders   8,065 209,931 3.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SAMRAT PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SAMRAT PHARMA vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SAMRAT PHARMA vs Glenmark Pharma Share Price Performance

Period SAMRAT PHARMA Glenmark Pharma S&P BSE HEALTHCARE
1-Day -1.87% -0.57% 1.18%
1-Month -10.12% 5.16% -0.75%
1-Year -2.44% 112.94% 61.82%
3-Year CAGR 34.42% 27.51% 18.16%
5-Year CAGR 38.09% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the SAMRAT PHARMA share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of SAMRAT PHARMA hold a 48.6% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SAMRAT PHARMA and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, SAMRAT PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 1.9%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of SAMRAT PHARMA, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.